Hyperplasia
MONDO:0005043An abnormal increase in the number of cells in an organ or a tissue with consequent enlargement.
Also known as: hyperplasia, hyperplastic
272 clinical trials for this condition and its sub-types, 5 tagged with Hyperplasia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Hyperplasia
-
Benign prostatic hyperplasia 225 trials
-
Atypical endometrial hyperplasia 28 trials
-
Atypical lobular breast hyperplasia 11 trials
-
Complex endometrial hyperplasia 3 trials
-
C-cell hyperplasia 0 trials
-
Adrenal medullary hyperplasia 0 trials
-
Focal epithelial hyperplasia 0 trials
-
Parathyroid hyperplasia 0 trials
-
Simple endometrial hyperplasia 0 trials
-
Urothelial hyperplasia 0 trials
2 sub-types
- Flat urothelial hyperplasia 0 trials
- Papillary urothelial hyperplasia 0 trials
-
Usual ductal breast hyperplasia 0 trials
-
Hormone pill tested for prostate troubles – but trial halted early
Disease control Stopped earlyThis phase 2 trial tested a hormone drug called etonogestrel (Org 3236) in 16 men with moderate to severe urinary symptoms from an enlarged prostate. The goal was to see if the drug could shrink the prostate, improve urine flow, and boost quality of life compared to a placebo. Ho…
Phase 2 • Sponsor: Organon and Co • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Promising prostate device trial halted after just one patient
Disease control Stopped earlyThis study tested a new device that uses water electrolysis to shrink prostate tissue and relieve urinary symptoms in men with benign prostatic hyperplasia (BPH). The goal was to see if it could improve symptoms by at least 30% and be safe. However, the trial was terminated early…
Sponsor: ProstaCare Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Breast cancer prevention study halted: tamoxifen pill vs. gel tested
Prevention Stopped earlyThis study aimed to see if a tamoxifen skin gel could work as well as the pill to lower breast cancer risk in women with certain high-risk breast conditions. The trial enrolled 65 women and compared short-term changes in breast tissue. However, the study was terminated early, so …
Phase 2 • Sponsor: Mayo Clinic • Aim: Prevention
Last updated Sep 03, 2026 00:00 UTC
-
Genetic test aims to improve breast cancer decisions for black and hispanic women
Knowledge-focused Stopped earlyThis study looked at whether adding a polygenic risk score (a genetic test) to standard breast cancer risk tools helps African American and Hispanic women make better decisions about screening and prevention. Researchers enrolled 19 women at higher risk for breast cancer. The stu…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC